Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Correlation of clinicopathologic features and driver gene mutation in non-small cell lung cancer].

Zhonghua bing li xue za zhi = Chinese journal of pathology - 8 Apr 2016

Chen L F, Chen X Y, Yu X B

Abstract excerpt

OBJECTIVE: To study the relationship between mutations of well-known driver genes and clinicopathologic characteristics of non-small cell lung cancers (NSCLC). METHODS: Scorpions amplification refractory mutation system (scorpions ARMS) fluorescence quantitative PCR was performed to investigate 205 driver gene mutation status in NSCLC in correlation with clinicopathological characteristics of the patients....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to ErbB Receptors
Share to EGFR gene

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, ras

Share to Lung Neoplasms

Share to Membrane Proteins

Share to Mutation

Share to Protein-Tyrosine Kinases

Source

Identifiers

PMID: 27033383
DOI: 10.3760/cma.j.issn.0529-5807.2016.04.002

Genes

EGFR
ALK
ROS1
BRAF
KRAS
NRAS
RET
EML4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Correlation of clinicopathologic features and driver gene mutation in non-small cell lung cancer].PMID 27033383Read ↗

[Advances on driver oncogenes of non-small cell lung cancer].Semantic proximity Read ↗

Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking status.Semantic proximity Read ↗

[Driver genes and its clinical significance in non-small cell lung cancer].Semantic proximity Read ↗

[EGFR and KRAS Gene Mutations in 754 Patients with Resectable Stage I-IIIa Non-small Cell Lung Cancer and Its Clinical Significance].Semantic proximity Read ↗

[Detection of ALK, ROS1 and RET fusion genes in non-small cell lung cancer patients and its clinicopathologic correlation].Semantic proximity Read ↗

[Clinicopathological significance in non-small cell lung cancer with mutations and co-mutations of EGFR, ALK and ROS1].Semantic proximity Read ↗

Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective.Semantic proximity Read ↗

Driver gene alterations in NSCLC patients in southern China and their correlation with clinicopathologic characteristicsSemantic proximity Read ↗

[Relationship between EGFR and KRAS mutations and prognosis in Chinese patients with non-small cell lung cancer: a mutation analysis with real-time polymerase chain reaction using scorpion amplification refractory mutation system].Semantic proximity Read ↗

[Advances on Driver Mutations of Small Cell Lung Cancer].Semantic proximity Read ↗

[Epidermal growth factor receptor gene mutations, amplification and clinicopathologic correlation in patients with lung cancer].Semantic proximity Read ↗

[Detection and Analysis of EGFR and KRAS Mutation with Lung Adenocarcinoma].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.